Listed

Adaptimmune Therapeutics PLC

ADAPYOTCCIK 1621227HealthcareFiscal year ends Dec 31

Reports and events: 279 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Adaptimmune Therapeutics PLC, Reports and events
FiledFormWhat it isAccession number
2017-05-2516:50 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-035235
2017-05-1616:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-033194
2017-05-1011:47 ET10-QQuarterly reportPeriod 2017-03-310001104659-17-031428
2017-05-1007:38 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-031339
2017-04-2816:48 ETDEF 14AProxy statementPeriod 2017-06-210001047469-17-003061
2017-04-1016:51 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-022631
2017-04-0616:39 ET10-Q/AQuarterly report, amendedPeriod 2016-09-300001104659-17-021990
2017-04-0509:12 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-021562
2017-03-3012:50 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-020261
2017-03-2217:25 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-018638
2017-03-1516:45 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-17-016654
2017-03-1416:45 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-17-016387
2017-03-1312:51 ET10-KAnnual reportPeriod 2016-12-310001104659-17-016024
2017-03-1307:43 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-17-015968
2017-01-0912:13 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-17-001464
2017-01-0908:21 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-17-001373
2016-12-1917:00 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-162841
2016-12-0507:48 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-16-160502
2016-11-2516:30 ET8-K1.02 Termination of a material agreement0001104659-16-159106
2016-11-1406:12 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-156438
2016-11-1009:29 ET10-QQuarterly reportPeriod 2016-09-300001104659-16-156035
2016-11-1006:43 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-16-155987
2016-11-0916:24 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-16-155869
2016-11-0816:42 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-16-155574
2016-10-2716:29 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-16-152603
2016-10-2716:29 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-152602
2016-10-1808:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-150614
2016-10-1216:40 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-149817
2016-09-2607:41 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-146421
2016-09-1907:40 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-145324
2016-08-1216:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-16-139355
2016-08-0811:14 ET10-QQuarterly reportPeriod 2016-06-300001104659-16-137807
2016-08-0807:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-16-137733
2016-08-0420:26 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-16-136699
2016-07-0816:47 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-16-131771
2016-06-2316:44 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-16-129072
2016-06-2107:49 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-128496
2016-06-2011:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-128237
2016-06-1606:50 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-16-127557
2016-06-0609:43 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-125544
2016-05-2409:55 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-16-122829
2016-05-1211:01 ET10-QQuarterly reportPeriod 2016-03-310001104659-16-120341
2016-05-1208:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-16-120271
2016-04-2916:46 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-116263
2016-04-2212:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-113452
2016-04-2208:36 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-113388
2016-04-1516:45 ET8-K8.01 Other events0001104659-16-111860
2016-04-0714:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-110316
2016-03-3008:46 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-108482
2016-03-1708:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-105692

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.